Zobrazeno 1 - 10
of 41
pro vyhledávání: '"R. Dafni"'
Autor:
W.W. Symes, R. Dafni
Publikováno v:
Proceedings.
Summary Subsurface offset extended imaging provides a possible link connecting migrated reflections in CIGs with the migration velocity error. However, it describes an artificial scattering geometry that splits the reflection point between incident a
We conducted a pilot clinical trial testing a personalized vaccine generated by autologous dendritic cells (DCs) pulsed with oxidized autologous whole-tumor cell lysate (OCDC), which was injected intranodally in platinum-treated, immunotherapy-naïve
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2127::e9bbae9e39374b3762eb7381d38dfa5e
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3123477
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3123477
Autor:
E. Duveneck, R. Dafni
Publikováno v:
Proceedings.
We present a method for automatically obtaining a detailed, accurate representation of a top-salt velocity model contrast, starting from a crude initial top-salt interpretation. The method is based on the analysis of time-shift gathers obtained in a
Background The tyrosine kinase inhibitor erlotinib improves the outcomes of patients with advanced non-small-cell lung carcinoma (NSCLC) harbouring epidermal growth factor receptor (EGFR) mutations. The coexistence of the T790M resistance mutation wi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2127::948deb7d9ad99b6849fc0239784c42f4
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3126192
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3126192
Autor:
R. Dafni, W.W. Symes
Publikováno v:
78th EAGE Conference and Exhibition 2016.
The ESMO Magnitude of Clinical Benefit Scale (ESMO-MCBS) is a standardised, generic, validated tool to stratify the magnitude of clinical benefit that can be anticipated from anticancer therapies. The ESMO-MCBS is intended to both assist oncologists
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2127::3c82d39833eaed9d27e02c746f0e7bb1
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3086612
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3086612
The value of any new therapeutic strategy or treatment is determined by the magnitude of its clinical benefit balanced against its cost. Evidence for clinical benefit from new treatment options is derived from clinical research, in particular phase I
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2127::0a10e6c9b1a01e2048f965948c698c46
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3109972
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3109972
Autor:
W. Kobusinski, P. Godlewski, Z. Mikolajewski, R. Dafni, Zvi Koren, H. Kowalski, M.W. Podolak, A. Nowicka, D. Chase, A. Canning, W. Makarewicz
Publikováno v:
First Break. 32
The exploration and development of shale plays in Europe show that the ‘statistical drilling’ approach used in some basins in recent years cannot be extended to areas where local stress in rocks or fracture distribution varies both laterally an